Brain MR Contribution to the Differential Diagnosis of Parkinsonian Syndromes: An Update

Parkinson's Disease

Volumn 2016, Issue , 2016, Pages

  Rizzo, Giovanni ^a,b   Zanigni, Stefano ^b,c   De Blasi, Roberto ^d   Grasso, Daniela ^d   Martino, Davide ^e,f   Savica, Rodolfo ^g   Logroscino, Giancarlo ^h  

^a BELLARIA HOSPITAL   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d Department of Diagnostic Imaging   (Italy)

^e KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^f LEWISHAM AND GREENWICH NHS TRUST   (United Kingdom)

^g MAYO CLINIC   (United States)

^h UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN ASYMMETRY; CEREBELLUM; CORTICOBASAL DEGENERATION; DIFFERENTIAL DIAGNOSIS; FRONTOPARIETAL CORTEX; HUMAN; MESENCEPHALON; MIDDLE CEREBELLAR PEDUNCLE; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PONS; PROGRESSIVE SUPRANUCLEAR PALSY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; SHY DRAGER SYNDROME; SUPERIOR CEREBELLAR PEDUNCLE;

EID: 84991296003     PISSN: None     EISSN: 20420080     Source Type: Journal    
DOI: 10.1155/2016/2983638     Document Type: Review

References (114)

1. G. Rizzo, M. Copetti, S. Arcuti, D. Martino, A. Fontana, and G. Logroscino, "Accuracy of clinical diagnosis of Parkinson disease, " Neurology, vol. 86, no. 6, pp. 566-576, 2016.
2. S. Sharma, C. S. Moon, A. Khogali et al., "Biomarkers in Parkinson's disease (recent update), " Neurochemistry International, vol. 63, no. 3, pp. 201-229, 2013.
3. M. Mascalchi, A. Vella, and R. Ceravolo, "Movement disorders: role of imaging in diagnosis, " Journal of Magnetic Resonance Imaging, vol. 35, no. 2, pp. 239-256, 2012.
4. S. T. Schwarz, M. Afzal, P. S. Morgan, N. Bajaj, P. A. Gowland, and D. P. Auer, "The 'swallow tail' appearance of the healthy nigrosome-A new accurate test of Parkinson's disease: a casecontrol and retrospective cross-sectionalMRI study at 3T, " PLoS ONE, vol. 9, no. 4, Article ID e93814, 2014.
5. P. Damier, E. C. Hirsch, Y. Agid, and A. M. Graybiel, "The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease, " Brain, vol. 122, no. 8, pp. 1437-1448, 1999.
6. A. I. Blazejewska, S. T. Schwarz, A. Pitiot et al., "Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI, " Neurology, vol. 81, no. 6, pp. 534-540, 2013.
7. P. Gao, P. Y. Zhou, G. Li et al., "Visualization of nigrosomes-1 in 3T MR susceptibility weighted imaging and its absence in diagnosing Parkinson's disease, " European Review for Medical and Pharmacological Sciences, vol. 19, no. 23, pp. 4603-4609, 2015.
8. E. Reiter, C. Mueller, B. Pinter et al., "Dorsolateral nigral hyperintensity on 3. 0T susceptibility-weighted imaging in neurodegenerative Parkinsonism, " Movement Disorders, vol. 30, no. 8, pp. 1068-1076, 2015.
9. L. Minati, M. Grisoli, F. Carella, T. De Simone, M. G. Bruzzone, and M. Savoiardo, "Imaging degeneration of the substantia Nigra in Parkinson disease with inversion-recovery MR imaging, " AmericanJournal of Neuroradiology, vol. 28, no. 2, pp. 309-313, 2007.
10. S. T. Schwarz, T. Rittman, V. Gontu, P. S. Morgan, N. Bajaj, and D. P. Auer, "T1-Weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease, " Movement Disorders, vol. 26, no. 9, pp. 1633-1638, 2011.
11. S. Reimão, P. Pita Lobo, D. Neutel et al., "Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients, " European Journal of Neurology, vol. 22, no. 3, pp. 540-546, 2015.
12. G. M. Halliday, J. L. Holton, T. Revesz, and D. W. Dickson, "Neuropathology underlying clinical variability in patients with synucleinopathies, " Acta Neuropathologica, vol. 122, no. 2, pp. 187-204, 2011.
13. T. Ozawa, D. Paviour, N. P. Quinn et al., "The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations, " Brain, vol. 127, no. 12, pp. 2657-2671, 2004.
14. W. L. Lee, C.-C. Lee, W.-C. Shyu, P.-N. Chong, and S.-Z. Lin, "Hyperintense putaminal rim sign is not a hallmark of multiple system atrophy at 3T, " American Journal of Neuroradiology, vol. 26, no. 9, pp. 2238-2242, 2005.
15. G. Arabia, M. Morelli, S. Paglionico et al., "An magnetic resonance imaging T2-weighted sequence at short echo timeto detect putaminal hypointensity in Parkinsonisms, " Movement Disorders, vol. 25, no. 16, pp. 2728-2734, 2010.
16. A. Sugiyama, S. Ito, T. Suichi et al., "Putaminal hypointensity on T2-weighted MR imaging is the most practically useful sign in diagnosing multiple system atrophy: a preliminary study, " Journal of the Neurological Sciences, vol. 349, no. 1-2, pp. 174-178, 2015.
17. I. Hwang, C.-H. Sohn, K. M. Kang et al., "Differentiation of Parkinsonism-predominantmultiple systematrophy fromidiopathic Parkinson disease using 3T susceptibility-weighted MR imaging, focusing on putaminal change and lesion asymmetry, " American Journal of Neuroradiology, vol. 36, no. 12, pp. 2227-2234, 2015.
18. F. J. A. Meijer, A. van Rumund, B. A. C. M. Fasen et al., "Susceptibility-weighted imaging improves the diagnostic accuracy of 3T brain MRI in the work-up of Parkinsonism, " American Journal of Neuroradiology, vol. 36, no. 3, pp. 454-460, 2015.
19. D. R. Williams and A. J. Lees, "Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges, " The Lancet Neurology, vol. 8, no. 3, pp. 270-279, 2009.
20. D. W. Dickson, Z. Ahmed, A. A. Algom, Y. Tsuboi, and K. A. Josephs, "Neuropathology of variants of progressive supranuclear palsy, " Current Opinion in Neurology, vol. 23, no. 4, pp. 394-400, 2010.
21. R. M. Liscic, K. Srulijes, A. Gröger, W. Maetzler, and D. Berg, "Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools, " Acta Neurologica Scandinavica, vol. 127, no. 5, pp. 362-370, 2013.
22. A. M. Grijalvo-Perez and I. Litvan, "Corticobasal degeneration, " Seminars in Neurology, vol. 34, no. 2, pp. 160-173, 2014.
23. F. J. A. Meijer, M. B. Aerts, W. F. Abdo et al., "Contribution of routine brain MRI to the differential diagnosis of Parkinsonism: a 3-year prospective follow-up study, " Journal of Neurology, vol. 259, no. 5, pp. 929-935, 2012.
24. R. F. Delgado, P. R. Sanchez, H. Speckter et al., "Missense PANK2 mutation without 'eye of the tiger' sign: MR findings in a large group of patients with Pantothenate Kinase-Associated Neurodegeneration (PKAN), " Journal of Magnetic Resonance Imaging, vol. 35, no. 4, pp. 788-794, 2012.
25. A. Stepens, I. Logina, V. Liguts et al., "A Parkinsonian syndrome in methcathinone users and the role of manganese, " The New England Journal of Medicine, vol. 358, no. 10, pp. 1009-1017, 2008.
26. D. A. Jacobs, C. E. Markowitz, D. S. Liebeskind, and S. L. Galetta, "The 'double panda sign' inWilson's disease, " Neurology, vol. 61, no. 7, p. 969, 2003.
27. P. Singh, A. Ahluwalia, K. Saggar, and C. S. Grewal, "Wilsons disease: MRI features, " Journal of Pediatric Neurosciences, vol. 6, no. 1, pp. 27-28, 2011.
28. G. öz, J. R. Alger, P. B. Barker et al., "Clinical proton MR spectroscopy in central nervous system disorders, " Radiology, vol. 270, no. 3, pp. 658-679, 2014.
29. G. Rizzo, C. Tonon, D. Manners, C. Testa, and R. Lodi, "Imaging brain functional and metabolic changes in restless legs syndrome, " CurrentNeurology andNeuroscience Reports, vol. 13, no. 9, article 372, 2013.
30. E. M. Haacke, N. Y. C. Cheng, M. J. House et al., "Imaging iron stores in the brain usingmagnetic resonance imaging, "Magnetic Resonance Imaging, vol. 23, no. 1, pp. 1-25, 2005.
31. G. Bartzokis, M. Aravagiri, W. H. Oldendorf, J. Mintz, and S. R. Marder, "Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores, " Magnetic Resonance in Medicine, vol. 29, no. 4, pp. 459-464, 1993.
32. J. H. Jensen, R. Chandra, A. Ramani et al., "Magnetic field correlation imaging, " Magnetic Resonance in Medicine, vol. 55, no. 6, pp. 1350-1361, 2006.
33. R. J. Ogg, J. W. Langston, E. M. Haacke, R. G. Steen, and J. S. Taylor, "The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration, " Magnetic Resonance Imaging, vol. 17, no. 8, pp. 1141-1148, 1999.
34. E. M. Haacke, Y. Xu, Y.-C. N. Cheng, and J. R. Reichenbach, "Susceptibilityweighted imaging (SWI), "Magnetic Resonance in Medicine, vol. 52, no. 3, pp. 612-618, 2004.
35. S. A. Smith, J. W. M. Bulte, and P. C. M. van Zijl, "Direct saturation MRI: theory and application to imaging brain iron, " Magnetic Resonance in Medicine, vol. 62, no. 2, pp. 384-393, 2009.
36. Y. Wang and T. Liu, "Quantitative susceptibility mapping (QSM): decoding MRI data for a tissue magnetic biomarker, " Magnetic Resonance in Medicine, vol. 73, no. 1, pp. 82-101, 2015.
37. A. Quattrone, G. Nicoletti, D. Messina et al., "MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant ofmultiple system atrophy, " Radiology, vol. 246, no. 1, pp. 214-221, 2008.
38. J. Ashburner and K. J. Friston, "Voxel-basedmorphometry-the methods, " NeuroImage, vol. 11, no. 6, pp. 805-821, 2000.
39. G. Rizzo, C. Tonon, C. Testa et al., "Abnormal medial thalamic metabolism in patients with idiopathic restless legs syndrome, " Brain, vol. 135, no. 12, pp. 3712-3720, 2012.
40. B. Fischl, M. I. Sereno, R. B. H. Tootell, and A. M. Dale, "Highresolution intersubject averaging and a coordinate system for the cortical surface, " Human Brain Mapping, vol. 8, no. 4, pp. 272-284, 1999.
41. G. Rizzo, C. Tonon, M. L. Valentino et al., "Brain diffusionweighted imaging in Friedreich's ataxia, " Movement Disorders, vol. 26, no. 4, pp. 705-712, 2011.
42. L. L. Gramegna, C. Tonon, D. N. Manners et al., "Combined cerebellar proton MR spectroscopy and DWI study of patients with Friedreich's Ataxia, " Cerebellum, pp. 1-7, 2016.
43. S. M. Smith, M. Jenkinson, H. Johansen-Berg et al., "Tractbased spatial statistics: voxelwise analysis of multi-subject diffusion data, " NeuroImage, vol. 31, no. 4, pp. 1487-1505, 2006.
44. S. Jbabdi and H. Johansen-Berg, "Tractography: wheredowe go from here" Brain Connectivity, vol. 1, no. 3, pp. 169-183, 2011.
45. R. M. Henkelman, G. J. Stanisz, and S. J. Graham, "Magnetization transfer in MRI: a review, " NMR in Biomedicine, vol. 14, no. 2, pp. 57-64, 2001.
46. N. Kato, K. Arai, and T. Hattori, "Study of the rostral midbrain atrophy in progressive supranuclear palsy, " Journal of the Neurological Sciences, vol. 210, no. 1-2, pp. 57-60, 2003.
47. H. Oba, A. Yagishita, H. Terada et al., "New and reliable MRI diagnosis for progressive supranuclear palsy, " Neurology, vol. 64, no. 12, pp. 2050-2055, 2005.
48. G. Nicoletti, F. Fera, F. Condino et al., "MR imaging of middle cerebellar peduncle width: differentiation of multiple system atrophy from Parkinson disease, " Radiology, vol. 239, no. 3, pp. 825-830, 2006.
49. R. L. Gama, D. F. G. Távora, R. C. Bomfim, C. E. Silva, V. M. de Bruin, and P. F. de Bruin, "Morphometry MRI in the differential diagnosis of Parkinsonian syndromes, " Arquivos de Neuro-Psiquiatria, vol. 68, no. 3, pp. 333-338, 2010.
50. A. Hussl, P. Mahlknecht, C. Scherfler et al., "Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy, " Movement Disorders, vol. 25, no. 14, pp. 2444-2449, 2010.
51. G. Longoni, F. Agosta, V. S. Kostíc et al., "MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-Parkinsonism, and Parkinson's disease, " Movement Disorders, vol. 26, no. 2, pp. 247-255, 2011.
52. M. Morelli, G. Arabia, M. Salsone et al., "Accuracy of magnetic resonance Parkinsonism index for differentiation of progressive supranuclear palsy from probable or possible Parkinson disease, " Movement Disorders, vol. 26, no. 3, pp. 527-533, 2011.
53. S. R. Nair, L. K. Tan, N. Mohd Ramli, S. Y. Lim, K. Rahmat, and H. Mohd Nor, "A decision tree for differentiating multiple system atrophy from Parkinson's disease using 3-T MR imaging, " European Radiology, vol. 23, no. 6, pp. 1459-1466, 2013.
54. S. Zanigni, G. Calandra-Buonaura, D. N. Manners et al., "Accuracy ofMRmarkers for differentiating Progressive Supranuclear Palsy fromParkinson's disease, "NeuroImage: Clinical, vol. 11, pp. 736-742, 2016.
55. J. B. Schulz, M. Skalej, D. Wedekind et al., "Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy, " Annals of Neurology, vol. 45, no. 1, pp. 65-74, 1999.
56. N. J. Cordato, C. Pantelis, G. M. Halliday et al., "Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy, " Brain, vol. 125, no. 4, pp. 789-800, 2002.
57. K. Gröschel, T.-K. Hauser, A. Luft et al., "Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration, " NeuroImage, vol. 21, no. 2, pp. 714-724, 2004.
58. D. C. Paviour, S. L. Price, J. M. Stevens, A. J. Lees, and N. C. Fox, "Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy, " Neurology, vol. 64, no. 4, pp. 675-679, 2005.
59. D. Paviour, S. L. Price, M. Jahanshahi, A. J. Lees, and N. C. Fox, "Regional brain volumes distinguish PSP, MSA-P, and PD: MRIbased clinico-radiological correlations, " Movement Disorders, vol. 21, no. 7, pp. 989-996, 2006.
60. D. Messina, A. Cerasa, F. Condino et al., "Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy, " Parkinsonism and Related Disorders, vol. 17, no. 3, pp. 172-176, 2011.
61. M. F. H. Schocke, K. Seppi, R. Esterhammer et al., "Diffusionweighted MRI differentiates the Parkinson variant of multiple systematrophy from PD, " Neurology, vol. 58, no. 4, pp. 575-580, 2002.
62. K. Seppi, M. F. H. Schocke, R. Esterhammer et al., "Diffusionweighted imaging discriminates progressive supranuclear palsy from PD, but not from the Parkinson variant ofmultiple system atrophy, " Neurology, vol. 60, no. 6, pp. 922-927, 2003.
63. M. F. H. Schocke, K. Seppi, R. Esterhammer et al., "Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease, " NeuroImage, vol. 21, no. 4, pp. 1443-1451, 2004.
64. K. Seppi, M. F. H. Schocke, E. Donnemiller et al., "Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patientswith the Parkinson variant ofmultiple systematrophy fromthose with Parkinson's disease, " Movement Disorders, vol. 19, no. 12, pp. 1438-1445, 2004.
65. K. Seppi, M. F. H. Schocke, K. Prennschuetz-Schuetzenau et al., "Topography of putaminal degeneration in multiple system atrophy: a diffusion magnetic resonance study, " Movement Disorders, vol. 21, no. 6, pp. 847-852, 2006.
66. G. Nicoletti, R. Lodi, F. Condino et al., "Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy, " Brain, vol. 129, no. 10, pp. 2679-2687, 2006.
67. D. C. Paviour, J. S. Thornton, A. J. Lees, and H. R. Jäger, "Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy, " Movement Disorders, vol. 22, no. 1, pp. 68-74, 2007.
68. M. Köllensperger, K. Seppi, C. Liener et al., "Diffusionweighted imaging best discriminates PD from MSA-P: a comparison with tilt table testing and heart MIBG scintigraphy, " Movement Disorders, vol. 22, no. 12, pp. 1771-1776, 2007.
69. G. Nicoletti, C. Tonon, R. Lodi et al., "Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease, " Movement Disorders, vol. 23, no. 16, pp. 2370-2376, 2008.
70. G. Rizzo, P. Martinelli, D. Manners et al., "Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease, " Brain, vol. 131, no. 10, pp. 2690-2700, 2008.
71. M. T. Pellecchia, P. B. Barone, C. Mollica et al., "Diffusionweighted imaging in multiple system atrophy: a comparison between clinical subtypes, " Movement Disorders, vol. 24, no. 5, pp. 689-696, 2009.
72. A. Umemura, T. Oeda, R. Hayashi et al., "Diagnostic accuracy of apparent diffusion coefficient and 123Imetaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease, " PLoS ONE, vol. 8, no. 4, Article ID e61066, 2013.
73. K. Tsukamoto, E. Matsusue, Y. Kanasaki et al., "Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3. 0-TMR imaging, " Neuroradiology, vol. 54, no. 9, pp. 947-955, 2012.
74. C. R. V. Blain, G. J. Barker, J. M. Jarosz et al., "Measuring brain stem and cerebellar damage in Parkinsonian syndromes using diffusion tensor MRI, " Neurology, vol. 67, no. 12, pp. 2199-2205, 2006.
75. M. Ito, H. Watanabe, Y. Kawai et al., "Usefulness of combined fractional anisotropy and apparent diffusion coefficient values for detection of involvement in multiple system atrophy, " Journal of Neurology, Neurosurgery and Psychiatry, vol. 78, no. 7, pp. 722-728, 2007.
76. S. Ito, T. Makino, W. Shirai, and T. Hattori, "Diffusion tensor analysis of corpus callosum in progressive supranuclear palsy, " Neuroradiology, vol. 50, no. 11, pp. 981-985, 2008.
77. E. J. Chung, E. G. Kim, J. S. Bae et al., "Usefulness of diffusionweighted MRI for differentiation between Parkinson's disease and Parkinson variant of multiple system atrophy, " Journal of Movement Disorders, vol. 2, no. 2, pp. 64-68, 2009.
78. A. Erbetta, M. L. Mandelli, M. Savoiardo et al., "Diffusion tensor imaging shows different topographic involvement of the thalamus in progressive supranuclear palsy and corticobasal degeneration, " American Journal of Neuroradiology, vol. 30, no. 8, pp. 1482-1487, 2009.
79. N. K. Focke, G. Helms, P. M. Pantel et al., "Differentiation of typical and atypical Parkinson syndromes by quantitative MR imaging, "AmericanJournal of Neuroradiology, vol. 32, no. 11, pp. 2087-2092, 2011.
80. K. Boelmans, N. C. Bodammer, B. Suchorska et al., "Diffusion tensor imaging of the corpus callosum differentiates corticobasal syndrome from Parkinson's disease, " Parkinsonism and Related Disorders, vol. 16, no. 8, pp. 498-502, 2010.
81. G. Nicoletti, G. Rizzo, G. Barbagallo et al., "Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or Parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease, " Radiology, vol. 267, no. 3, pp. 843-850, 2013.
82. J. Prodoehl, H. Li, P. J. Planetta et al., "Diffusion tensor imaging of Parkinson's disease, atypical Parkinsonism, and essential tremor, " MovementDisorders, vol. 28, no. 13, pp. 1816-1822, 2013.
83. S. Baudrexel, C. Seifried, B. Penndorf et al., "The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy, " Movement Disorders, vol. 29, no. 3, pp. 380-387, 2014.
84. C. P. Hess, C. W. Christine, A. C. Apple, W. P. Dillon, and M. J. Aminoff, "Changes in the thalamus in atypical Parkinsonism detected using shape analysis and diffusion tensor imaging, " American Journal of Neuroradiology, vol. 39, no. 5, pp. 897-903, 2014.
85. C. Nilsson, K. Markenroth Bloch, S. Brockstedt, J. Lätt, H. Widner, and E.-M. Larsson, "Tracking the neurodegeneration of Parkinsonian disorders-A pilot study, " Neuroradiology, vol. 49, no. 2, pp. 111-119, 2007.
86. Y. Surova, F. Szczepankiewicz, J. Lätt et al., "Assessmentof global and regional diffusion changes along white matter tracts in Parkinsonian disorders by MR tractography, " PLoS ONE, vol. 8, no. 6, article e66022, 2013.
87. J. Rosskopf, H.-P. Müller, H.-J. Huppertz, A. C. Ludolph, E. H. Pinkhardt, and J. Kassubek, "Frontal corpus callosum alterations in progressive supranuclear palsy but not in Parkinson's disease, " Neurodegenerative Diseases, vol. 14, no. 4, pp. 184-193, 2014.
88. Y. Surova, M. Nilsson, J. Lätt et al., "Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy, " Neuroradiology, vol. 57, no. 11, pp. 1079-1091, 2015.
89. F. J. A. Meijer, A. van Rumund, A. M. Tuladhar et al., "Conventional 3T brain MRI and diffusion tensor imaging in the diagnostic workup of early stage Parkinsonism, " Neuroradiology, vol. 57, no. 7, pp. 655-669, 2015.
90. T. Eckert, M. Sailer, J. Kaufmann et al., "Differentiation of idiopathic Parkinson's disease, multiple systematrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging, " NeuroImage, vol. 21, no. 1, pp. 229-235, 2004.
91. F. von Lewinski, C. Werner, T. Jörn, A. Mohr, F. Sixel-Döring, and C. Trenkwalder, "T2-weighted MRI in diagnosis of multiple system atrophy. A practical approach for clinicians, " Journal of Neurology, vol. 254, no. 9, pp. 1184-1188, 2007.
92. D. Gupta, J. Saini, C. Kesavadas, P. S. Sarma, and A. Kishore, "Utility of susceptibility-weighted MRI in differentiating Parkinson's disease and atypical Parkinsonism, " Neuroradiology, vol. 52, no. 12, pp. 1087-1094, 2010.
93. K. Boelmans, B. Holst, M. Hackius et al., "Brain iron deposition fingerprints in Parkinson's disease and progressive supranuclear palsy, " Movement Disorders, vol. 27, no. 3, pp. 421-427, 2012.
94. Y. Wang, S. R. Butros, X. Shuai et al., "Different iron-deposition patterns of multiple system atrophy with predominant Parkinsonism and idiopathetic Parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging, " American Journal of Neuroradiology, vol. 33, no. 2, pp. 266-273, 2012.
95. Y.-H. Han, J.-H. Lee, B.-M. Kang et al., "Topographical differences of brain iron deposition between progressive supranuclear palsy and Parkinsonian variant multiple system atrophy, " Journal of the Neurological Sciences, vol. 325, no. 1-2, pp. 29-35, 2013.
96. J.-H. Lee, Y.-H. Han, B.-M. Kang, C.-W. Mun, S.-J. Lee, and S.-K. Baik, "Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and Parkinsonian variant of multiple system atrophy, " Journal of Neurology, vol. 260, no. 8, pp. 2094-2101, 2013.
97. R. G. Yoon, S. J. Kim, H. S. Kim et al., "The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography, " Neuroscience Letters, vol. 584, pp. 296-301, 2015.
98. C. A. Davie, G. K. Wenning, G. J. Barker et al., "Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy, " Annals of Neurology, vol. 37, no. 2, pp. 204-210, 1995.
99. F. Federico, I. L. Simone, V. Lucivero et al., "Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy, " Journal of Neurology, Neurosurgery and Psychiatry, vol. 62, no. 3, pp. 239-242, 1997.
100. F. Federico, I. L. Simone, V. Lucivero et al., "Proton magnetic resonance spectroscopy in Parkinson's disease and atypical Parkinsonian disorders, " Movement Disorders, vol. 12, no. 6, pp. 903-909, 1997.
101. G. Tedeschi, I. Litvan, S. Bonavita et al., "Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration, " Brain, vol. 120, no. 9, pp. 1541-1552, 1997.
102. F. Federico, I. L. Simone, V. Lucivero et al., "Usefulnessofproton magnetic resonance spectroscopy in differentiating Parkinsonian syndromes, " The Italian Journal of Neurological Sciences, vol. 20, no. 4, pp. 223-229, 1999.
103. K. Abe, H. Terakawa, M. Takanashi et al., "Proton magnetic resonance spectroscopy of patients with Parkinsonism, " Brain Research Bulletin, vol. 52, no. 6, pp. 589-595, 2000.
104. C. E. Clarke and M. Lowry, "Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophymeasured by protonmagnetic resonance spectroscopy, " European Journal of Neurology, vol. 7, no. 6, pp. 661-665, 2000.
105. H. Watanabe, H. Fukatsu, and M. Katsuno, "Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker, " Journal of Neurology, Neurosurgery and Psychiatry, vol. 75, no. 1, pp. 103-109, 2004.
106. L. F. R. Vasconcellos, S. A. PereiraNovis, D. M. Moreira, A. L. Z. Rosso, and A. C. C. B. Leite, "Neuroimaging in Parkinsonism: a study with magnetic resonance and spectroscopy as tools in the differential diagnosis, " Arquivos de Neuro-Psiquiatria, vol. 67, no. 1, pp. 1-6, 2009.
107. C. A. Guevara, C. R. Blain, D. Stahl, D. J. Lythgoe, P. N. Leigh, and G. J. Barker, "Quantitative magnetic resonance spectroscopic imaging in Parkinson's disease, progressive supranuclear palsy andmultiple systematrophy, " European Journal of Neurology, vol. 17, no. 9, pp. 1193-1202, 2010.
108. S. Zanigni, C. Testa, G. Calandra-Buonaura et al., "The contribution of cerebellar proton magnetic resonance spectroscopy in the differential diagnosis among Parkinsonian syndromes, " Parkinsonism and Related Disorders, vol. 21, no. 8, pp. 929-937, 2015.
109. W. R. W. Martin, M. Wieler, and M. Gee, "Midbrain iron content in early Parkinson disease: a potential biomarker of disease status, " Neurology, vol. 70, no. 16, pp. 1411-1417, 2008.
110. P. Péran, A. Cherubini, F. Assogna et al., "Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature, " Brain, vol. 133, no. 11, pp. 3423-3433, 2010.
111. A. Gröger, B. Bender, I. Wurster, G. L. Chadzynski, U. Klose, and D. Berg, "Differentiation between idiopathic and atypical Parkinsonian syndromes using three-dimensional magnetic resonance spectroscopic imaging, " Journal of Neurology, Neurosurgery and Psychiatry, vol. 84, no. 6, pp. 644-649, 2013.
112. D. E. Vaillancourt, M. B. Spraker, J. Prodoehl et al., "Highresolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease, " Neurology, vol. 72, no. 16, pp. 1378-1384, 2009.
113. J. Langley, D. E. Huddleston, M. Merritt et al., "Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisited, " Human Brain Mapping, vol. 3, no. 7, pp. 2547-2556, 2016.
114. D. K. Jones and M. Cercignani, "Twenty-five pitfalls in the analysis of diffusion MRI data, " NMR in Biomedicine, vol. 23, no. 7, pp. 803-820, 2010.